HomeFHTX • NASDAQ
add
Foghorn Therapeutics Inc.
Previous close
$5.81
Day range
$5.47 - $6.02
Year range
$2.70 - $9.97
Market cap
234.65M USD
Avg Volume
73.16K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 5.05M | -4.88% |
Operating expense | 7.71M | -10.77% |
Net income | -25.02M | 17.95% |
Net profit margin | -495.37 | 13.74% |
Earnings per share | -0.59 | 19.18% |
EBITDA | -27.36M | 15.71% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 206.66M | -34.59% |
Total assets | 255.00M | -31.61% |
Total liabilities | 352.49M | -11.32% |
Total equity | -97.49M | — |
Shares outstanding | 42.59M | — |
Price to book | -2.54 | — |
Return on assets | -26.06% | — |
Return on capital | 162.74% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -25.02M | 17.95% |
Cash from operations | -29.34M | 5.89% |
Cash from investing | 27.10M | -8.17% |
Cash from financing | 1.17M | 1,044.12% |
Net change in cash | -1.08M | 31.15% |
Free cash flow | -18.92M | -26.63% |
About
Founded
2015
Website
Employees
116